"Hepatitis B e Antigens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A closely related group of antigens found in the plasma only during the infective phase of hepatitis B or in virulent chronic hepatitis B, probably indicating active virus replication; there are three subtypes which may exist in a complex with immunoglobulins G.
| Descriptor ID |
D006513
|
| MeSH Number(s) |
D23.050.327.495.500.469
|
| Concept/Terms |
Hepatitis B e Antigens- Hepatitis B e Antigens
- Hepatitis Be Antigens
- Antigens, Hepatitis Be
- Be Antigens, Hepatitis
- e Antigens
- Antigens, e
- HBeAg
|
Below are MeSH descriptors whose meaning is more general than "Hepatitis B e Antigens".
Below are MeSH descriptors whose meaning is more specific than "Hepatitis B e Antigens".
This graph shows the total number of publications written about "Hepatitis B e Antigens" by people in this website by year, and whether "Hepatitis B e Antigens" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 1 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2010 | 1 | 0 | 1 |
| 2013 | 0 | 2 | 2 |
| 2014 | 0 | 3 | 3 |
| 2017 | 12 | 21 | 33 |
| 2018 | 8 | 9 | 17 |
| 2019 | 7 | 4 | 11 |
| 2020 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Hepatitis B e Antigens" by people in Profiles.
-
A case series of COVID-19 patients with chronic hepatitis B virus infection. J Med Virol. 2020 11; 92(11):2785-2791.
-
Occult hepatitis B and HIV infection. Eur J Gastroenterol Hepatol. 2019 Nov; 31(11):1403-1407.
-
Modelling cost-effectiveness of tenofovir for prevention of mother to child transmission of hepatitis B virus (HBV) infection in South Africa. BMC Public Health. 2019 Jun 26; 19(1):829.
-
When (and When Not) to Treat Patients With HBV Infection. Clin Gastroenterol Hepatol. 2019 12; 17(13):2644-2647.
-
Sustained serological and complete responses in HBeAg-positive patients treated with Peginterferon alfa-2b: a 6-year long-term follow-up of a multicenter, randomized, controlled trial in China. BMC Gastroenterol. 2019 May 02; 19(1):65.
-
Hepatitis B e antigen induces the expansion of monocytic myeloid-derived suppressor cells to dampen T-cell function in chronic hepatitis B virus infection. PLoS Pathog. 2019 04; 15(4):e1007690.
-
Relationship between hepatitis B core-related antigen levels and sustained HBeAg seroconversion in patients treated with nucleo(s)tide analogues. J Viral Hepat. 2019 07; 26(7):828-834.
-
Efficacy and safety of long-term therapy with nucleos(t)ide analogues in chronic hepatitis B. Ter Arkh. 2019 Mar 18; 91(2):40-47.
-
Epidemiological trends and virological traits of hepatitis B virus infection in pregnant women and neonates. Arch Virol. 2019 May; 164(5):1335-1341.
-
OX40 stimulation and PD-L1 blockade synergistically augment HBV-specific CD4 T cells in patients with HBeAg-negative infection. J Hepatol. 2019 06; 70(6):1103-1113.